연구동향 분석

건강검진자에서 전립선 크기와 대사인자 및 Prostate-Specific Antigen과의 관계

나은희 조한익 최중찬 2014년

논문상세정보
    • 저자 나은희 조한익 최중찬
    • 제어번호 101598612
    • 학술지명 Laboratory Medicine Online
    • 권호사항 Vol. 4 No. 4 [ 2014 ]
    • 발행처 대한진단검사의학회
    • 자료유형 학술저널
    • 수록면 212-217
    • 언어 Korean
    • 출판년도 2014
    • 등재정보 KCI등재
    • 판매처
    유사주제 논문( 0)
인용/피인용

' 건강검진자에서 전립선 크기와 대사인자 및 Prostate-Specific Antigen과의 관계' 의 참고문헌

  • The development of human benign prostatic hyperplasia with age
    Berry SJ J Urol 132 474-479 [1984]
  • The association of metabolic syndrome and its components with serum prostate-specific antigen levels in a Korean-screened population
    Jeong IG Cancer Epidemiol Biomarkers Prev 19 371-380 [2010]
  • The association of body mass index and prostate-specific antigen in a population-based study
    Baillargeon J Cancer 103 1092-1095 [2005]
  • Sex hormone-binding globulin is a major determinant of the lipid profile : the PRIME study
    Bataille V Atherosclerosis 179 369-373 [2005]
  • Serum prostate-specific antigen as a predictor of prostate volume in the community : The Krimpen study
    Bohnen AM Eur Urology 51 1645-1652 [2007]
  • Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study
    Roehrborn CG J Urol 163 13-20 [2000]
  • Screening and prostate-cancer mortality in a randomized European study
    Schröder FH N Engl J Med 360 1320-1328 [2009]
  • Relationships between Prostate-Specific Antigen, Prostate Volume, and Components of Metabolic Syndrome in Healthy Korean Men
    Hyun Keun Byun Investigative and Clinical Urology 53 11 774-778 [2012]
  • Relationship between serum prostate-specific antigen levels and components of metabolic syndrome in healthy men
    Han JH Urology 72 749-754 [2008]
  • Relationship between prostate specific antigen, prostate volume and age in the benign prostate
    Collins GN Br J Urol 71 445-450 [1993]
  • Relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms
    Kwon H Urology 81 1325-1329 [2013]
  • Relationship between Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Metabolic Syndrome in Korean Men
    Yeon Won Park The World Journal of Men's Health 30 3 183-188 [2012]
  • Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia
    Mochtar CA Eur Urol 44 695-700 [2003]
  • Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention
    Marberger MJ Eur Urol 38 563-568 [2000]
  • Prostate volume and prostate-specific antigen in the absence prostate cancer : a review of the relationship and prediction of long-term outcomes
    Lieber MM Prostate 49 208-212 [2001]
  • Prostate specific antigen best practice statement: 2009 update
    Greene KL J Urol 189 S1 S2-S11 [2013]
  • Prostate specific antigen : a decade of discovery-what we have learned and where we are going
    Polascik TJ J Urol 162 293-306 [1999]
  • Obesity related hyperinsulinaemia and hyperglycemia and cancer development
    Becker S Arch Physiol Biochem 115 86-96 [2009]
  • Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004
    Werny DM Cancer Epidemiol Biomarkers Prev 16 70-76 [2007]
  • Obesity and benign prostatic hyperplasia: Clinical connections, emerging etiological paradigms and future directions
    Parsons JK J Urol 189 S1 S102-S106 [2013]
  • Obesity and benign prostatic hyperplasia
    Giovannucci E Am J Epidemiol 140 989-1002 [1994]
  • Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community
    Bosch JL Urology 46 S1 34-40 [1995]
  • Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia
    Hammarsten J Eur Urol 39 151-158 [2001]
  • Formula-derived prostate volume determination
    Aarnink RG Eur Urol 29 399-402 [1996]
  • Etiology of benign prostatic hyperplasia
    Lee C Urol Clin North Am 22 237-246 [1995]
  • Endogenous testosterone and serum lipids in middle-aged men
    Mäkinen JI Atherosclerosis 197 688-693 [2008]
  • Effect of obesity and body fat distribution on sex hormones and insulin in men
    Pasquali R Metabolism 40 101-104 [1991]
  • Benign prostatic hyperplasia : A progressive disease of aging men
    Emberton M Urology 61 267-273 [2003]
  • Anthropometric and metabolic factors and risk of benign prostatic hyperplasia : a prospective cohort study of Air Force veterans
    Gupta A Urology 68 1198-1205 [2006]